| Application no. and date | 14171739.7 (espacenet) (Federated) (European Patent Register), 20050708 | | Patent/reg. no. and date | DK/EP 2801583, 20180425 | | Publication date | 20141112 | | Priority no. and date | US 586581 P, 20040710 | | EP pub. no. and date |
EP 2801583 20141112 | | Effective date | | | Applicant/owner | The Institute for Cancer Research, 333 Cottman Avenue
Philadelphia
Pennsylvania 19111, US | | Applicant ref. no. | P65138DK01 | | Inventor | Campbell, Kerry S., 2 Hemlock Lane
Wyncote, PA 19095, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 35/12 (2015.01) , A61K 35/17 (2015.01) , A61K 39/395 (2006.01) , A61K 49/00 (2006.01) , C07K 14/735 (2006.01) , C07K 16/28 (2006.01) , C07K 16/32 (2006.01) , C12N 5/0783 (2010.01) , G01N 33/50 (2006.01) | | Title | Genetisk modificerede humane naturlige dræbercellelinjer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
